Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial

ClinicalTrials.gov ID: NCT00035815

Public ClinicalTrials.gov record NCT00035815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 3:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS)

Study identification

NCT ID
NCT00035815
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mayo Clinic
Other
Enrollment
330 participants

Conditions and interventions

Interventions

  • Insulin like growth factor, type 1 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2003
Primary completion
Jul 31, 2007
Completion
Nov 30, 2007
Last update posted
Feb 14, 2013

2003 – 2007

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Mayo Clinic in Scottsdale Scottsdale Arizona 85259
California Pacific Medical Center San Francisco California 94115
Mayo Clinic in Jacksonville Jacksonville Florida 32224
Emory University Atlanta Georgia 30322
Indiana University Indianapolis Indiana 46202
University of Michigan Medical Center Ann Arbor Michigan 48109
Henry Ford Hospital Detroit Michigan 48202
Hennepin County Medical Center Minneapolis Minnesota 55404
Mayo Clinic Rochester Minnesota 55905
University of Mississippi Jackson Mississippi 39216
Beth Israel Medical Center New York New York 10003
University of Rochester Medical Center Rochester New York 14642
University of Cincinnati Cincinnati Ohio 45219
Cleveland Clinic Cleveland Ohio 44195
Ohio State University Columbus Ohio 43210
University of Pennsylvania, Pennsylvania Hospital Philadelphia Pennsylvania 19107
Methodist Hospital Houston Texas 77030
West Virginia University Morgantown West Virginia 26506
Froedtert and Medical College Clinics Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2013 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00035815 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →